Clinical trials: Ankylosed Joints

Rheumatoid Arthritis, Ankylosing Spondylitis

99mTc-rhAnnexin V-128 a Phase I/IIa Study in Patients With Rheumatoid Arthritis (RA) or Ankylosing Spondylitis (AS)

• Terminated
• Age: 18 years and older
• Phase 1/2
• Results posted

This was a monocentric, open label, Phase I-IIa study. Eligible patients who signed the ICF received two single intravenous (IV) bolus of the imaging agent 99mTc-rhAnnexin V-128.

Trial name

NCT02328027

Testing

99mTc-rhAnnexin V-128

Where

Switzerland

Volunteers

16 people

Sponsor

Advanced Accelerator Applications